5268

Bilcare Limited Stock Price

BSE:526853 Community·₹1.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

526853 Share Price Performance

₹86.44
28.66 (49.60%)
₹86.44
28.66 (49.60%)
Price ₹86.44

526853 Community Narratives

There are no narratives available yet.

Recent 526853 News & Updates

Bilcare Limited Key Details

₹7.8b

Revenue

₹5.3b

Cost of Revenue

₹2.5b

Gross Profit

₹2.7b

Other Expenses

-₹261.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 14, 2025
Earnings per share (EPS)
-11.09
Gross Margin
31.68%
Net Profit Margin
-3.35%
Debt/Equity Ratio
115.6%

Bilcare Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Good value with adequate balance sheet.

3 Risks
1 Reward

About 526853

Founded
1987
Employees
78
CEO
Mohan Bhandari
WebsiteView website
www.bilcare-group.com

Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.8%
  • 3 Months: -1.3%
  • 1 Year: -2.3%
  • Year to Date: 1.1%
The market is up 1.8% over the last week, with the Financials sector leading the way, up 2.6%. As for last year, the market performance has been flat. Looking forward, earnings are forecast to grow by 16% annually. Market details ›